Zhang, Xue
Zhao, Ling-Xiao
Cheng, Si-Qi
Liu, Ye-Fu
Funding for this research was provided by:
Science and Technology Program of Liaoning Province (2024-BS-322)
Liaoning Provincial Key Laboratory of Precision Medicine for Malignant Tumors (Project number: 220569)
Article History
Received: 9 September 2024
Accepted: 7 February 2025
First Online: 20 February 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Liaoning Cancer Hospital (Approval Number: KY20240501).
: All participants gave written informed consent prior to participation. Personal information was anonymized and deidentified to protect participant privacy. Our study was completed in accordance with the Declaration of Helsinki. All experiments were performed in accordance with relevant guidelines and regulations. The datasets generated during the current study are available from the corresponding author on reasonable request.
: The authors declare no competing interests.